OSR HEALTH, INC. Effective Tax Rate
OSR HEALTH, INC. (OSRH) reported Effective Tax Rate of -14.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-22.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2025-04-22
- OSR HEALTH, INC. effective income tax rate reconciliation, percent for the quarter ending 2024-03-31 was 21.00%, a 0.00% change year-over-year.
- OSR HEALTH, INC. effective income tax rate reconciliation, percent for the quarter ending 2023-03-31 was 21.00%.
- OSR HEALTH, INC. effective income tax rate reconciliation, percent for fiscal 2024 was -14.00%, a 124.48% decline from fiscal 2023.
- OSR HEALTH, INC. effective income tax rate reconciliation, percent for fiscal 2023 was 57.20%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 12 month | Effective Income Tax Rate Reconciliation, Percent 12 month as first filed |
|---|---|---|---|
| 2024-12-31 | -14.00% 10-K · filed 2025-04-22 | ||
| 2024-03-31 | 21.00% 10-Q · filed 2024-05-15 | ||
| 2023-12-31 | 57.20% 10-K · filed 2025-04-22 | 21.00% 10-K · filed 2024-04-17 | |
| 2023-03-31 | 21.00% 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |